Metabolics Pharma Reports Promising Phase 1a Results for ENT-03
DOYLESTOWN, PA — Metabolics Pharma has announced top-line results from a Phase 1a clinical trial of ENT-03, its investigational drug for obese and diabetic patients. The trial demonstrated that ENT-03 …
Metabolics Pharma Reports Promising Phase 1a Results for ENT-03 Read More